Job Cuts As Nordic Nanovector Extends Cash Runway

Biotech’s Priority Is Pivotal Betalutin Study But COVID-19 Uncertainty Remains

 
• By Sten Stovall
  
Runway_24
Nordic Nanovector has extended its cash runway by restructuring, cutting costs. • Source: Shutterstock

More from Business

More from Scrip